These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 102259)

  • 1. Inactivation of purine nucleoside phosphorylase by modification of arginine residues.
    Jordan F; Wu A
    Arch Biochem Biophys; 1978 Oct; 190(2):699-704. PubMed ID: 102259
    [No Abstract]   [Full Text] [Related]  

  • 2. Rabbit erythrocyte purine nucleoside phosphorylase. Differential-inactivation studies.
    Savage B; Spencer N
    Biochem J; 1979 Apr; 179(1):29-34. PubMed ID: 112995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inactivation by 4,6 disubstituted pyrazolo (3,4-d) pyrimidines of the arsenolysis of guanosine by erythrocyte purine nucleoside phosphorylase].
    Thang KV; Delbarre F; Auscher C; Gerbaut L
    C R Acad Hebd Seances Acad Sci D; 1977 Feb; 284(6):481-3. PubMed ID: 404078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit erythrocyte purine nucleoside phosphorylase. Initial-velocity studies.
    Savage B; Spencer N
    Biochem J; 1979 Apr; 179(1):21-7. PubMed ID: 112994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of purine nucleoside phosphorylase by 9-(phosphonoalkyl)hypoxanthines.
    Nakamura CE; Chu SH; Stoeckler JD; Parks RE
    Biochem Pharmacol; 1986 Jan; 35(2):133-6. PubMed ID: 3080002
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiviral acyclic nucleoside phosphonate analogues as inhibitors of purine nucleoside phosphorylase.
    Kulikowska E; Bzowska A; Holy A; Magnowska L; Shugar D
    Adv Exp Med Biol; 1998; 431():747-52. PubMed ID: 9598163
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of 9-(3,4-dioxopentyl)hypoxanthine, the first arginine-directed purine derivative: an irreversible inactivator for purine nucleoside phosphorylase.
    Salamone SJ; Jordan F
    Biochemistry; 1982 Dec; 21(25):6383-8. PubMed ID: 6817790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of purine nucleoside phosphorylase, C(8) and C(5') substitutions.
    Stoeckler JD; Cambor C; Kuhns V; Chu SH; Parks RE
    Biochem Pharmacol; 1982 Jan; 31(2):163-71. PubMed ID: 6800381
    [No Abstract]   [Full Text] [Related]  

  • 9. Nucleotide analogue inhibitors of purine nucleoside phosphorylase.
    Krenitsky TA; Tuttle JV; Miller WH; Moorman AR; Orr GF; Beauchamp L
    J Biol Chem; 1990 Feb; 265(6):3066-9. PubMed ID: 2105941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of purine nucleoside phosphorylase and mitogen-stimulated transformation in immunocompetent murine spleen cells by formycin B.
    Willemot J; Martineau R; DesRosiers C; Kelly S; Létourneau J; Lalanne M
    Life Sci; 1979 Oct; 25(14):1215-22. PubMed ID: 117271
    [No Abstract]   [Full Text] [Related]  

  • 11. 31P NMR studies on purine nucleoside phosphorylases: determination of the scissile bond and of the equilibrium constant.
    Salamone SJ; Jordan F; Jordan RR
    Arch Biochem Biophys; 1982 Aug; 217(1):139-43. PubMed ID: 6812503
    [No Abstract]   [Full Text] [Related]  

  • 12. Partial purification and properties of purine nucleoside phosphorylase from rabbit erythrocytes.
    Savage B; Spencer N
    Biochem J; 1977 Dec; 167(3):703-10. PubMed ID: 414743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A MTT-linked spot test for the detection of 'silent' phenotypes of purine nucleoside phosphorylase (NP) in cattle erythrocytes.
    Ansay M; Baldewijns-Rouma V; Smith JE
    Anim Blood Groups Biochem Genet; 1975; 6(4):249-50. PubMed ID: 813546
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification and characterization of human erythrocyte purine nucleoside phosphorylase and its subunits.
    Zannis V; Doyle D; Martin DW
    J Biol Chem; 1978 Jan; 253(2):504-10. PubMed ID: 412851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of adenosine deaminase and purine nucleoside phosphorylase and T-cell function in germfree mice and human peripheral blood.
    Wiedl SC; Bealmear PM; Epstein J
    Prog Clin Biol Res; 1985; 181():461-6. PubMed ID: 3927311
    [No Abstract]   [Full Text] [Related]  

  • 16. 8-Amino-9-substituted guanines: potent purine nucleoside phosphorylase (PNP) inhibitors.
    Sircar JC; Kostlan CR; Pinter GW; Suto MJ; Bobovski TP; Capiris T; Schwender CF; Dong MK; Scott ME; Bennett MK
    Agents Actions; 1987 Aug; 21(3-4):253-6. PubMed ID: 3120506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purine nucleoside phosphorylase from human erythrocytes.
    Stoeckler JD; Agarwal RP; Agarwal KC; Parks RE
    Methods Enzymol; 1978; 51():530-8. PubMed ID: 99639
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts.
    Kazmers IS; Mitchell BS; Dadonna PE; Wotring LL; Townsend LB; Kelley WN
    Science; 1981 Dec; 214(4525):1137-9. PubMed ID: 6795718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human erythrocyte purine nucleoside phosphorylase: molecular weight and physical properties. A Theorell-Chance catalytic mechanism.
    Lewis AS; Lowy BA
    J Biol Chem; 1979 Oct; 254(19):9927-32. PubMed ID: 114517
    [No Abstract]   [Full Text] [Related]  

  • 20. Assay of purine nucleoside phosphorylase in erythrocytes by flow-injection analysis with fluorescence detection.
    Hayashi Y; Zaitsu K; Ohkura Y
    Chem Pharm Bull (Tokyo); 1987 Nov; 35(11):4574-8. PubMed ID: 3127063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.